Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease.

作者: R. Caswell‐Smith , A. Hosking , T. Cripps , C. Holweg , J. Matthews

DOI: 10.1111/CEA.12763

关键词:

摘要: SummaryBackground The clinical utility of serum periostin as a type 2 biomarker in asthma is limited by lack reference range values derived from population without respiratory disease. Objective To derive age- and sex-related intervals for an adult or COPD. Methods Serum levels were measured 480 individuals, comprising 60 female male adults each the 18- to 30-year, 31- 45-year, 46- 60-year 61- 75-year age groups. Key exclusion criteria included doctor's diagnosis asthma, chronic bronchitis COPD, history wheezing use inhalers last 12 months. The distribution logarithm-transformed was derived, 90% confidence individual prediction calculated. Results The right skewed with mean (SD) 51.2 (11.9) ng/mL, median (IQR) 50.1 (43.1 56.9) ng/mL 28.1 136.4 ng/mL. There no association between logarithm sex, although low current smokers. limits 35.0 71.1 ng/mL. Conclusions Clinical Relevance Serum COPD are similar those asthma. Serum measurements do not need be adjusted take account patient's lower Reference provided.

参考文章(37)
S Takeshita, R Kikuno, K Tezuka, E Amann, Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochemical Journal. ,vol. 294, pp. 271- 278 ,(1993) , 10.1042/BJ2940271
Allen H Reed, Richard J Henry, William B Mason, Influence of Statistical Method Used on the Resulting Estimate of Normal Range Clinical Chemistry. ,vol. 17, pp. 275- 284 ,(1971) , 10.1093/CLINCHEM/17.4.275
E. D. Gordon, S. S. Sidhu, Z.‐E. Wang, P. G. Woodruff, S. Yuan, M. C. Solon, S. J. Conway, X. Huang, R. M. Locksley, J. V. Fahy, A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clinical & Experimental Allergy. ,vol. 42, pp. 144- 155 ,(2012) , 10.1111/J.1365-2222.2011.03840.X
Eijiro Oku, Taisuke Kanaji, Yuka Takata, Koichi Oshima, Ritsuko Seki, Satoshi Morishige, Rie Imamura, Korenori Ohtsubo, Michitoshi Hashiguchi, Koichi Osaki, Kazuaki Yakushiji, Kohji Yoshimoto, Hideaki Ogata, Hirofumi Hamada, Kenji Izuhara, Michio Sata, Takashi Okamura, Periostin and bone marrow fibrosis International Journal of Hematology. ,vol. 88, pp. 57- 63 ,(2008) , 10.1007/S12185-008-0095-2
Simon J. Conway, Thomas Doetschman, Mohamad Azhar, The Inter-Relationship of Periostin, TGFβ, and BMP in Heart Valve Development and Valvular Heart Diseases The Scientific World Journal. ,vol. 11, pp. 1509- 1524 ,(2011) , 10.1100/TSW.2011.132
Stanley J. Szefler, Sally Wenzel, Robert Brown, Serpil C. Erzurum, John V. Fahy, Robert G. Hamilton, John F. Hunt, Hirohito Kita, Andrew H. Liu, Reynold A. Panettieri, Robert P. Schleimer, Michael Minnicozzi, Asthma outcomes: Biomarkers Journal of Allergy and Clinical Immunology. ,vol. 129, pp. S9- S23 ,(2012) , 10.1016/J.JACI.2011.12.979
Prescott G. Woodruff, Barmak Modrek, David F. Choy, Guiquan Jia, Alexander R. Abbas, Almut Ellwanger, Joseph R. Arron, Laura L. Koth, John V. Fahy, T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma American Journal of Respiratory and Critical Care Medicine. ,vol. 180, pp. 388- 395 ,(2009) , 10.1164/RCCM.200903-0392OC
Go Takayama, Kazuhiko Arima, Taisuke Kanaji, Shuji Toda, Hiroyuki Tanaka, Shunsuke Shoji, Andrew N.J. McKenzie, Hiroichi Nagai, Takao Hotokebuchi, Kenji Izuhara, Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals The Journal of Allergy and Clinical Immunology. ,vol. 118, pp. 98- 104 ,(2006) , 10.1016/J.JACI.2006.02.046
Simon J. Conway, Kenji Izuhara, Yasusei Kudo, Judith Litvin, Roger Markwald, Gaoliang Ouyang, Joseph R. Arron, Cecile T. J. Holweg, Akira Kudo, The role of periostin in tissue remodeling across health and disease. Cellular and Molecular Life Sciences. ,vol. 71, pp. 1279- 1288 ,(2014) , 10.1007/S00018-013-1494-Y